These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 8653879)

  • 1. Dichotomy of ischemic preconditioning: improved postischemic contractile function despite intensification of ischemic contracture.
    Kolocassides KG; Galinanes M; Hearse DJ
    Circulation; 1996 May; 93(9):1725-33. PubMed ID: 8653879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preconditioning accelerates contracture and ATP depletion in blood-perfused rat hearts.
    Kolocassides KG; Galiñanes M; Hearse DJ
    Am J Physiol; 1995 Oct; 269(4 Pt 2):H1415-20. PubMed ID: 7485575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can ischemic preconditioning ensure optimal myocardial protection when delivery of cardioplegia is impaired?
    Galiñanes M; Argano V; Hearse DJ
    Circulation; 1995 Nov; 92(9 Suppl):II389-94. PubMed ID: 7586443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cardioplegia on vascular function and the "no-reflow" phenomenon after ischemia and reperfusion: studies in the isolated blood-perfused rat heart.
    Argano V; Galiñanes M; Edmondson S; Hearse DJ
    J Thorac Cardiovasc Surg; 1996 Feb; 111(2):432-41; discussion 441-2. PubMed ID: 8583818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired cardioplegic delivery and the loss of cardioprotection: a role for preconditioning.
    Galiñanes M; Wilson AN; Hearse DJ
    J Mol Cell Cardiol; 1997 Feb; 29(2):849-54. PubMed ID: 9140842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein kinase C isoform-dependent myocardial protection by ischemic preconditioning and potassium cardioplegia.
    Lu K; Otani H; Yamamura T; Nakao Y; Hattori R; Ninomiya H; Osako M; Imamura H
    J Thorac Cardiovasc Surg; 2001 Jan; 121(1):137-48. PubMed ID: 11135170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of nicorandil as an additive to the solution for continuous warm cardioplegia.
    Qiu Y; Galiñanes M; Hearse DJ
    J Thorac Cardiovasc Surg; 1995 Oct; 110(4 Pt 1):1063-72. PubMed ID: 7475135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ischemic preconditioning is not additive to preservation with hypothermia or crystalloid cardioplegia in the globally ischemic rat heart.
    Juggi JS; al-Awadi F; Joseph S; Telahoun G; Prahash A
    Mol Cell Biochem; 1997 Nov; 176(1-2):303-13. PubMed ID: 9406176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ischemic preconditioning, cardioplegia or both? Differing approaches to myocardial and vascular protection.
    Kolocassides KG; Galiñanes M; Hearse DJ
    J Mol Cell Cardiol; 1996 Mar; 28(3):623-34. PubMed ID: 9011645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of ischemic preconditioning on the recovery of myocardial function after unprotected ischemia and cardioplegia in the isolated and crystalloid perfused rat hearts].
    Otani H; Kawasaki H; Ninomiya H; Kido M; Kawaguchi H; Osako M; Kato Y; Imamura H
    Nihon Kyobu Geka Gakkai Zasshi; 1997 Jan; 45(1):23-30. PubMed ID: 9028119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-related changes in the ability of hypothermia and cardioplegia to protect ischemic rabbit myocardium.
    Baker JE; Boerboom LE; Olinger GN
    J Thorac Cardiovasc Surg; 1988 Nov; 96(5):717-24. PubMed ID: 3184966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection of the myocardium during global ischemia. Is crystalloid cardioplegia effective in the immature myocardium?
    Avkiran M; Hearse DJ
    J Thorac Cardiovasc Surg; 1989 Feb; 97(2):220-8. PubMed ID: 2915557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial protection with oxygenated esmolol cardioplegia during prolonged normothermic ischemia in the rat.
    Bessho R; Chambers DJ
    J Thorac Cardiovasc Surg; 2002 Aug; 124(2):340-51. PubMed ID: 12167795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine-enhanced ischemic preconditioning provides enhanced postischemic recovery and limitation of infarct size in the rabbit heart.
    McCully JD; Uematsu M; Parker RA; Levitsky S
    J Thorac Cardiovasc Surg; 1998 Jul; 116(1):154-62. PubMed ID: 9671910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between preischemic hypothermia and cardioplegic solutions in the neonatal lamb heart.
    Aoki M; Nomura F; Mayer JE
    J Thorac Cardiovasc Surg; 1994 Mar; 107(3):822-8. PubMed ID: 8127111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained protection by acadesine against ischemia- and reperfusion-induced injury. Studies in the transplanted rat heart.
    Galiñanes M; Bullough D; Mullane KM; Hearse DJ
    Circulation; 1992 Aug; 86(2):589-97. PubMed ID: 1638724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ischemic preconditioning, cardioplegia or both?
    Kolocassides KG; Galiñanes M; Hearse DJ
    J Mol Cell Cardiol; 1994 Nov; 26(11):1411-4. PubMed ID: 7897664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ischemic preconditioning improves preservation with crystalloid cardioplegia.
    Illes RW; Wright JK; Inners-McBride K; Yang CJ; Tristan A
    Ann Thorac Surg; 1994 Nov; 58(5):1481-5. PubMed ID: 7979679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paradoxical effect of ischemic preconditioning on ischemic contracture? NMR studies of energy metabolism and intracellular pH in the rat heart.
    Kolocassides KG; Seymour AM; Galiñanes M; Hearse DJ
    J Mol Cell Cardiol; 1996 May; 28(5):1045-57. PubMed ID: 8762042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial protection: the efficacy of an ultra-short-acting beta-blocker, esmolol, as a cardioplegic agent.
    Bessho R; Chambers DJ
    J Thorac Cardiovasc Surg; 2001 Nov; 122(5):993-1003. PubMed ID: 11689806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.